Cefiderocol: An Overview of Its in-vitro and in-vivo Activity and Underlying Resistant Mechanisms

Treatment of multidrug-resistant (MDR) Gram-negative bacteria (GNB) infections has led to a global public health challenging due to the bacterial resistance and limited choices of antibiotics. Cefiderocol (CFDC), a novel siderophore cephalosporin possessed unique drug delivery systems and stability...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiahui, Wang, Jin, Chen, Mengli, Cai, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688709/
https://www.ncbi.nlm.nih.gov/pubmed/34950677
http://dx.doi.org/10.3389/fmed.2021.741940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688709/
https://www.ncbi.nlm.nih.gov/pubmed/34950677
http://dx.doi.org/10.3389/fmed.2021.741940

Ejemplares similares